Functional mechanism of malate dehydrogenase 2 in tumors

Abstract

Wu Ying1, Fu Baixue, Dai Lu, Huang Jun, Teng Yibin, Li Linlin, Zhang Jingwen, Huang Yuhong. Functional mechanism of malate dehydrogenase 2 in tumors[J]. Journal of International Oncology, 2019, 46(3): 178-180.

References

［1］ Liu R, Wang H, Liu J, et al. Uncovering the embryonic developmentrelated proteome and metabolome signatures in breast muscle and intramuscular fat of fastand slowgrowing chickens［J］. BMC Genomics, 2017, 18(1): 816. DOI: 10.1186/s1286401741503. ［2］ AitElMkadem S, DayemQuere M, Gusic M, et al. Mutations in MDH2, encoding a Krebs cycle enzyme, cause earlyonset severe encephalopathy［J］. Am J Hum Genet, 2017, 100(1): 151159. DOI: 10.1016/j.ajhg.2016.11.014. ［3］ Oldham WM, Clish CB, Yang Y, et al. Hypoxiamediated increases in L2hydroxyglutarate coordinate the metabolic response to reductive stress［J］. Cell Metab, 2015, 22(2): 291303. DOI: 10.1016/j.cmet.2015.06.021. ［4］ Lo YW, Lin ST, Chang SJ, et al. Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicinresistant uterine cancer［J］. J Cell Mol Med, 2015, 19(4): 744759. DOI: 10.1111/jcmm.12388. ［5］ Kim BS, Lee K, Jung HJ, et al. HIF1α suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1［J］. Biochem Biophys Res Commun, 2015, 458(1): 1420. DOI: 10.1016/j.bbrc.2015.01.031. ［6］ Taniguchi S, Shimatani Y, Fujimori M, et al. Tumortargeting therapy using geneengineered anaerobicnonpathogenic bifidobacterium longum［J］. Methods Mol Biol, 2016, 1409: 4960. DOI: 10.1007/9781493935154_5. ［7］ Zhuang Y, Xiang J, Bao W, et al. MDH2 stimulated by estrogenGPR30 pathway downregulated PTEN expression promoting the proliferation and invasion of cells in endometrial cancer［J］. Transl Oncol, 2017, 10(2): 203210. DOI: 10.1016/j.tranon.2017.01.009. ［8］ Ban HS, Xu X, Jang K, et al. A novel malate dehydrogenase 2 inhibitor suppresses hypoxiainducible factor1 by regulating mitochondrial respiration［J］. PLoS One, 2016, 11(9): e0162568. DOI: 10.1371/journal.pone.0162568. ［9］ Wei J, Yang Y, Lu M, et al. Recent advances in the discovery of HIF1αp300/CBP inhibitors as anticancer agents［J］. Mini Rev Med Chem, 2018, 18(4): 296309. DOI: 10.2174/1389557516666160630124938. ［10］ Lima Queiroz A, Zhang B, Comstock DE, et al. miR1265p targets malate dehydrogenase 1 in nonsmall cell lung carcinomas［J］. Biochem Biophys Res Commun, 2018, 499(2): 314320. DOI: 10.1016/j.bbrc.2018.03.154. ［11］ Latonen L, Afyouniab E, Jylh A, et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression［J］. Nat Commun, 2018, 9(1): 1176. DOI: 10.1038/s41467018035736. ［12］ Cascón A, CominoMéndez I, CurrásFreixes M, et al. Wholeexome sequencing identifies MDH2 as a new familial paragangliomagene［J］. J Natl Cancer Inst, 2015, 107(5): pii: djv053. DOI: 10.1093/jnci/djv053. ［13］ Liu Y, Asnani A, Zou L, et al. Visnagin protects against doxorubicininduced cardiomyopathy through modulation of mitochondrial malate dehydrogenase［J］. Sci Transl Med, 2014, 6(266): 266170. DOI: 10.1126/scitranslmed.3010189. ［14］ Beezhold K, Byersdorfer CA. Targeting immunometabolism to improve anticancer therapies［J］. Cancer Lett, 2018, 414: 127135. DOI: 10.1016/j.canlet.2017.11.005. ［15］ Ylip A, Kivinummi K, Kohvakka A, et al. Transcriptome sequencing reveals PCAT5 as a novel ERGregulated long noncoding RNA in prostate cancer［J］. Cancer Res, 2015, 75(19): 40264031. DOI: 10.1158/00085472.CAN150217. ［16］ Kratochvilova M, Raudenska M, Heger Z, et al. Amino acid profiling of zinc resistant prostate cancer cell lines: associations with cancer progression［J］. Prostate, 2017, 77(6): 604616. DOI: 10.1002/pros.23304. ［17］ Shen H, Hau E, Joshi S, et al. Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism［J］. Mol Cancer Ther, 2015, 14(8): 17941804. DOI: 10.1158/15357163.MCT150247. ［18］ Gentric G, Kieffer Y, Mieulet V, et al. PMLregulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers［J］. Cell Metab, 2019, 29(1): 156173.e10. DOI: 10.1016/j.cmet.2018.09.002. ［19］ Zhang B, Tornmalm J, Widengren J, et al. Characterization of the role of the malate dehydrogenases to lung tumor cell survival［J］. J Cancer, 2017, 8(11): 20882096. DOI: 10.7150/jca.19373. ［20］ Xi L. Visnagin—a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond［J］. Ann Transl Med, 2016, 4(4): 65. DOI: 10.3978/j.issn.23055839.2015.10.43. ［21］ Ippolito L, Marini A, Cavallini L, et al. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells［J］. Oncotarget, 2016, 7(38): 6189061904. DOI: 10.18632/oncotarget.11301. ［22］ Ciccarone F, Vegliante R, Di Leo L, et al. The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer［J］. Semin Cancer Biol, 2017, 47: 5056. DOI: 10.1016/j.semcancer.2017.06.008. ［23］ Jochmanová I, Zhuang Z, Pacak K. Pheochromocytoma: gasping for air［J］. Horm Cancer, 2015, 6(56): 191205. DOI: 10.1007/s1267201502314. ［24］ Chen C, Zhang LG, Liu J, et al. Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data［J］. Onco Targets Ther, 2016, 9: 15451557. DOI: 10.2147/OTT.S98807.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.